The pharmaceutical industry is busy pushing and churning out new “miracle” drugs that, based on the science, actually accelerate the diseases they supposedly treat. Take corticosteroids, for instance. Two recent studies show that this class of pharmaceutical, which is commonly used to treat osteoarthritis in the knees, actually contributes to the progression of the disease. “Statistical analysis showed that … Continue reading New FDA-approved “miracle” drugs ACCELERATE formation of arthritis, Alzheimer’s
FDA approves controversial drug for use against Alzheimer’s disease, despite evidence showing it doesn’t work
The Food and Drug Administration (FDA) recently approved a drug for Alzheimer’s disease despite warnings from experts that the controversial treatment hasn’t been shown to slow the disease. American biotechnology company Biogen developed the drug with Japanese pharmaceutical company Esai. The drug, known as aducanumab, is the first Alzheimer’s treatment approved by the FDA in almost 20 years. It will be marketed … Continue reading FDA approves controversial drug for use against Alzheimer’s disease, despite evidence showing it doesn’t work
ICER: FDA failed to protect patients from unproven Alzheimer’s treatment with known harms
The Food and Drug Administration (FDA) drew criticisms after granting Alzheimer’s disease drug Aduhelm a conditional approval. It allows the drug scientifically known as aducanumab to be prescribed and used while its maker Biogen conducts a post-marketing, phase 4 confirmatory study that could take years to complete. Aduhelm is the first Alzheimer’s medication approved by the FDA since … Continue reading ICER: FDA failed to protect patients from unproven Alzheimer’s treatment with known harms
Dr. Eddy Bettermann MD 